Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLTA pseudogene 1 (CLTAP1)
- Target
- CLTAP1
- Molecular classification
- Pseudogene, Non-coding RNA
01
Overview
CLTA pseudogene 1 (CLTAP1) is a genomic sequence related to the gene encoding clathrin light chain A, but it is a pseudogene—meaning it does not produce a functional protein due to accumulated disabling mutations. While some pseudogenes are transcribed into RNA and can modulate the activity of regulatory pathways, there is no evidence published on CLTA pseudogene 1 being functionally relevant as a biomarker, therapeutic target, or regulator in human disease. In general, pseudogenes are not considered therapeutic targets, and "CLTA pseudogene 1" should not be mistaken for the protein-coding clathrin light chain A gene (CLTA), which has established roles in endocytosis and cellular trafficking.
- Other names
- CLTA pseudogenepseudogene of Clathrin light chain ACLTAP1
02
Mechanism of action
Not applicable
03
Biological functions
No direct protein functionpseudogenes can regulate gene expression as non-coding RNAs (e.g. acting as competing endogenous RNAs or as sources of small RNAs), but there is no evidence for a biological role for "CLTA pseudogene 1" specifically
04
Disease associations
None established for CLTA pseudogene 1pseudogenes in general can play regulatory roles in cancer and other diseases, but there is no specific evidence for this particular pseudogene
Beyond the preview
Go deeper on CLTA pseudogene 1 (CLTAP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CLTA pseudogene 1 (CLTAP1).